About 1 500 reports

Cancer Drug News 27 JULY 2015

16 pages • By Espicom Business Intelligence

Industry Trend Analysis - Oncology Will Be Driving Force Of BMS' RevenuesIndustry Brief - CASI Pharmaceuticals Launches Zevalin For NHLIndustry Brief - FDA Approval Sought For Arzerra As Maintenance Therapy For Relapsed CLLIndustry Brief - EMA Validates Empliciti MAA For MMIndustry Trend Analysis - Looming Competition Overshadows...

825 1 114 685
Jul 2015

Global Opthalmic Therapeutic Market 2015-2019

146 pages • By Infiniti Research Limited

About Ophthalmic DiseasesOphthalmology is the science of eyes. It is the branch of medicine concerned with the treatment of eye-related diseases and eye defects. Some of the common eye disorders are glaucoma, retinal diseases, conjunctivitis, refractive errors, color blindness, and retinitis. Many of the eye diseases do not show symptoms...

2 400 3 000 1 920
Jul 2015

Nonalcoholicsteatohepatitis (NASH) - Pipeline Analysis

112 pages • By IQ4I Research & Consultancy Pvt. Ltd

“Nonalcoholicsteatohepatitis(NASH)PipelineAnalysis”givescomprehensiveinsightonthevariousdrugsbeingdevelopedforthetreatmentofNASH.Thereportcoversallthedrugsbeingdevelopedinvariousphases(Discovery,Preclinical&Clinicaldevelopment).Thepipelinefocusesonnovelmedicinescoveringsmallmolecules,monoclonalantibodies,RecombinantproteinsandRNA-basedtherapeutics,butexcludesOff-label,symptomreliefdrugs,genericcombinations.ThereportalsocovershottargetsinresearchforNASHtreatmentsanddiseaseprogressionbiomarkers.ThisreportenablesPharmaceutical/Biotechcompanies,Academicinstitutes,Individualresearchers,Investors,Medicaltechnologycompanies,Serviceprovidersandotherassociatedstakeholderstoidentifyandanalyzetheavailablelicensing/collaborativecommercialopportunitiesintheNonalcoholicsteatohepatitis(NASH)Drugmarket.ThereportalsoprovidesstrategicinsightsonmedicinesthatarelikelytohaveanimpactonfutureNASHtreatmentspace.NASHisassociatedwithfattyliver,hepaticinflammation,hepatocyteinjuryandfibrogenesisandmayworsenintofibrosisorcirrhosis,liverfailureandrarelyintolivercancer.Currently,therearenoapproveddrugsforNASHbyU.S.FoodandDrugAdministration(FDA)andthereahighunmetclinicalneed.NASH,ifuntreatedcanprogresstoliver-destroyingcirrhosisandpotentiallycancer.MajorityoftheNASHpipelinedrugsarefromspecialisedsmalltomidpharmaceutical&biotechcompanies.AssomeofthecandidatesarenearingkeyR&Dmilestones,thereisahugecompetitionamonglargepharmaceuticalandbiotechcompaniestoacquiretheseassets.Gilead’sacquisitionofPhenexFXRprogram&Boehringer’sacquisitionofNASHclinicalassetfromPharmaxissupportsthistrend.DiagnosisofNASHstillrequireshistologicalconfirmationandthereisagreatdemandforspecificnon-invasivediagnosisfordistinguishingNASHfromotherliverdiseases.Therefore,thereisaneedtodevelopbetterdiagnosticandtherapeuticstrategiesforpatientswithNASH.ThereisatremendousopportunityforupcomingtherapiesspecifictoNASHsuchasMAbs,RNA-basedtherapies&Recombinantproteins.ThesemodalitiesmayprovideAnti-fibrosis,Anti-inflammatoryandmetabolicbenefits.

2 880 3 600 2 304
Jul 2015

Cancer Drug News 13 JULY 2015

12 pages • By Espicom Business Intelligence

Industry Trend Analysis - Atezolizumab Will Be Significant Anti-PD-1 Competitor In 2016Industry Brief - EU Approval Sought For Arzerra As Maintenance Therapy For Relapsed CLLIndustry Brief - Daratumumab EAP Open To Eligible MM Patients In USIndustry Brief - Imbruvica Gains EU Approval For WMIndustry Brief - Mylan Launches Bexarotene...

825 1 114 685
Jul 2015

Global Diabetes Drug Therapy Industry Report 2015

237 pages • By QY Research Group

SummaryThe Global Diabetes Drug Therapy Industry Report 2015 is a professional and in-depth study on the current state of the Diabetes Drug Therapy industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Diabetes Drug Therapy...

2 240 2 800 1 792
Jul 2015

Cancer Drug News 06 JULY 2015

24 pages • By Espicom Business Intelligence

Industry Trend Analysis - Bespoke Medicine Success Reliant On Manufacturing EfficiencesIndustry Trend Analysis - Cost Will Impact Perjeta's Success In EuropeIndustry Brief - Takeda's Adcetris First Ultra-Orphan Medicine Recommended By AWMSGIndustry Brief - CHMP Adopts Positive Opinion On Novartis' Farydak For MMIndustry Brief...

825 1 114 685
Jul 2015

Global Oncology Partnering 2010-2015: Deal trends, players and financials

5583 pages • By Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service.The Global Oncology Partnering 2010-2015 report provides an understanding and access to the oncology partnering deals and agreements entered into...

2 796 3 495 2 237
Jul 2015

Therapy Markets in China

218 pages • By Asia Market Information & Development Company

China's demand for Therapy has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over...

3 200 4 000 2 560
Jul 2015

LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists -Pipeline Insights, 2015

By Delve Insight

SummaryDelveInsight’s, LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology,...

1 000 1 250 800
Jul 2015

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment

279 pages • By Kelly Scientific Publications

Cutting-edge new research by KellySciPub indicates that the core personalized medicine market will be worth over $60 billion by 2019. This market is made up of companion diagnostics and targeted therapeutics and is currently worth $42 billion. This market is dominated by oncology, cardiovascular and infectious disease treatment and diagnostics....

2 720 3 400 2 176
Jul 2015

Non-Small Cell Lung Cancer: KOL Insight

By Firstword Pharma

Non-Small Cell Lung Cancer: KOL Insight offers detailed expert opinion on the continuing evolution of the treatment paradigm for EGFR/ALK positive and negative NSCLC, and the potential for targeting KRAS-mutation positive disease.The treatment of advanced NSCLC...

5 996 7 495 5 217
Jul 2015

Brain Injury Global Clinical Trials Review, H1, 2015

87 pages • By Global Data

Brain Injury Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, “Brain Injury Global Clinical Trials Review, H1, 2015" provides an overview of Brain Injury clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Injury. Report includes an overview...

2 000 2 500 1 600
Jun 2015

Dental Pain Global Clinical Trials Review, H1, 2015

83 pages • By Global Data

Dental Pain Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, “Dental Pain Global Clinical Trials Review, H1, 2015" provides an overview of Dental Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Dental Pain. Report includes an overview...

2 000 2 500 1 600
Jun 2015

Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015

120 pages • By Global Data

Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, “Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015" provides an overview of Human Papillomavirus Infections clinical trials scenario. This report provides top line data relating to the...

2 000 2 500 1 600
Jun 2015

Joint Pain Global Clinical Trials Review, H1, 2015

78 pages • By Global Data

Joint Pain Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, “Joint Pain Global Clinical Trials Review, H1, 2015" provides an overview of Joint Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Joint Pain. Report includes an overview of...

2 000 2 500 1 600
Jun 2015

Cancer Pain Global Clinical Trials Review, H1, 2015

90 pages • By Global Data

Cancer Pain Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, H1, 2015" provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. Report includes an overview...

2 000 2 500 1 600
Jun 2015

Candidiasis Global Clinical Trials Review, H1, 2015

101 pages • By Global Data

Candidiasis Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, “Candidiasis Global Clinical Trials Review, H1, 2015" provides an overview of Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Candidiasis. Report includes an overview...

2 000 2 500 1 600
Jun 2015

Inguinal Hernia Global Clinical Trials Review, H1, 2015

85 pages • By Global Data

Inguinal Hernia Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, “Inguinal Hernia Global Clinical Trials Review, H1, 2015" provides an overview of Inguinal Hernia clinical trials scenario. This report provides top line data relating to the clinical trials on Inguinal Hernia. Report includes...

2 000 2 500 1 600
Jun 2015

Hemostasis Global Clinical Trials Review, H1, 2015

93 pages • By Global Data

Hemostasis Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, “Hemostasis Global Clinical Trials Review, H1, 2015" provides an overview of Hemostasis clinical trials scenario. This report provides top line data relating to the clinical trials on Hemostasis. Report includes an overview of...

2 000 2 500 1 600
Jun 2015

Escherichia Coli Infections Global Clinical Trials Review, H1, 2015

74 pages • By Global Data

Escherichia Coli Infections Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, “Escherichia Coli Infections Global Clinical Trials Review, H1, 2015" provides an overview of Escherichia Coli Infections clinical trials scenario. This report provides top line data relating to the clinical...

2 000 2 500 1 600
Jun 2015

Hernia Global Clinical Trials Review, H1, 2015

81 pages • By Global Data

Hernia Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, “Hernia Global Clinical Trials Review, H1, 2015" provides an overview of Hernia clinical trials scenario. This report provides top line data relating to the clinical trials on Hernia. Report includes an overview of trial numbers...

2 000 2 500 1 600
Jun 2015

Lupus Nephritis Global Clinical Trials Review, H1, 2015

78 pages • By Global Data

Lupus Nephritis Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, “Lupus Nephritis Global Clinical Trials Review, H1, 2015" provides an overview of Lupus Nephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Nephritis. Report includes...

2 000 2 500 1 600
Jun 2015

Chronic Stable Angina Global Clinical Trials Review, H1, 2015

74 pages • By Global Data

Chronic Stable Angina Global Clinical Trials Review, H1, 2015SummaryGlobalData's clinical trial report, “Chronic Stable Angina Global Clinical Trials Review, H1, 2015" provides an overview of Chronic Stable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic...

2 000 2 500 1 600
Jun 2015

Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019

71 pages • By Infiniti Research Limited

About PTSDPTSD is a psychological condition that develops after a person is exposed to any traumatic event, and it drains a person emotionally. According to the DSM-IV codes found in the Diagnostic and Statistical Manual of Mental Disorders, published by the American Psychiatric Association (APA), PTSD is classified under anxiety disorders....

2 000 2 500 1 600
Jun 2015

Protein Kinase Inhibitors Drug Pathway Analyzer 2015

By Bioseeker

Extra value: One year of free online updates included with this productThere are today at least 995 protein kinase inhibitor drugs known to affect more than 250 specific intracellular signaling pathways for the treatment of more than 142 different tumor types. The rational for this plethora of treatment strategies is based on our increasing...

2 785 4 178 2 228
Jun 2015

Nucleic Acid Therapies in Oncology Drug Pipeline Update 2015

By Bioseeker

Nucleic acid therapies in oncology includes: Gene Therapy, DNA vaccine, Other DNA technologies, RNA Interference (RNAi), Small interfering RNA (siRNA), Antisense RNA and Ribozymes.There are today 281 companies plus partners developing 338 nucleic acid therapy drugs in 825 developmental projects in cancer. In addition, there are 9 suspended...

2 093 3 139 1 674
Jun 2015

Cataract Global Clinical Trials Review, H1, 2015

79 pages • By Global Data

Cataract Global Clinical Trials Review, H1, 2015 SummaryGlobalData's clinical trial report, “Cataract Global Clinical Trials Review, H1, 2015" provides an overview of Cataract clinical trials scenario. This report provides top line data relating to the clinical trials on Cataract. Report includes an overview of trial...

2 000 2 500 1 600
Jun 2015

Impetigo Global Clinical Trials Review, H1, 2015

82 pages • By Global Data

Impetigo Global Clinical Trials Review, H1, 2015 SummaryGlobalData's clinical trial report, “Impetigo Global Clinical Trials Review, H1, 2015" provides an overview of Impetigo clinical trials scenario. This report provides top line data relating to the clinical trials on Impetigo. Report includes an overview of trial...

2 000 2 500 1 600
Jun 2015

Glaucoma Global Clinical Trials Review, H1, 2015

105 pages • By Global Data

Glaucoma Global Clinical Trials Review, H1, 2015 SummaryGlobalData's clinical trial report, “Glaucoma Global Clinical Trials Review, H1, 2015" provides an overview of Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Glaucoma. Report includes an overview of trial...

2 000 2 500 1 600
Jun 2015

Ocular Hypertension Global Clinical Trials Review, H1, 2015

102 pages • By Global Data

Ocular Hypertension Global Clinical Trials Review, H1, 2015 SummaryGlobalData's clinical trial report, “Ocular Hypertension Global Clinical Trials Review, H1, 2015" provides an overview of Ocular Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Ocular Hypertension....

2 000 2 500 1 600
Jun 2015